Home The Company How we work History Group Structure Management Team Board of Directors Technology The ExpreS2 Platform About S2 cells ExpreS2 Kit Transfection Reagents FAQs Vaccines Placental Malaria Vaccine Blood Stage Malaria Vaccine Other Malaria work Services Custom Proteins and R&D Reagents Process Development Feasibility Studies Licensing Investor Pressmeddelanden (SE) Press Releases (EN) Other News Financial Calendar Shareholder Information Reports & Presentations IPO Nyemission 2017 Bolagsbeskrivning Bolagsstyrning Investor Relations Bolagsstämma News Pressmeddelanden (SE) Press Releases (EN) Subscribe to News Other News Publications Meet Us Contact AdaptVAC Investor Custom Proteins Transfection Reagent Licensing Process Development ‹ › We’re Here To Solve Your Biggest Protein Challenges We are a team of highly experienced scientists specialised in developing cell lines and processes based on a non-viral Drosophila S2 cells expression system. We are driven by a very focused passion for helping our partners solve their most critical and unique recombinant protein challenges. Our stable and flexible ExpreS2 recombinant protein expression platform perfectly supports all phases of drug discovery, R&D and manufacturing. Boost your R&D Our ExpreS2 platform can provide you with the complex proteins you need for your research. Since we started our company in 2010, more than 250 proteins have been successfully expressed in our system. For some of these, the ExpreS2 system was the only system that was able to provide the correct form of the desired protein. Enable or expedite your pipeline Our team of experts can help you get the proteins you need fast. Because the ExpreS2 platform is seamless from R&D to commercial manufacturing, no bridging studies in protein expression, quality and activity are needed when starting with ExpreS2. With their unique characteristics and stable expression, S2 cells allow cell line development and process development to take place in parallel, saving time significantly. We also support your process transfer and regulatory needs. Find out more about our ExpreS2 platform and how to license it for in-house use. Get in touch to discuss your challenge. ﻿ Vaccines Passionate about fighting neglected diseases such as malaria, dengue fever, chikungunya, ExpreS2ion uses its ExpreS2 platform to support malaria research and vaccine development. Read more » The ExpreS2 Platform ExpreS2 is a non-viral insect cell expression system that quickly establishes stable polyclonal pools that provide high protein expression levels without selection pressure. Read more » News Read the latest news and get the latest publications from ExpreS2ion Biotechnologies. Read more » ExpreS2ion Biotechnologies Agern Allé 1, DK-2970 Horsholm, Denmark E-mail: info@expres2ionbio.com Phone: +45 4256 6869 Follow Us · © 2017 ExpreS2ion Biotechnologies · Designed by Press Customizr · Powered by · Back to top